Skip to content

Clinical trials

Lymphoma, Large B-Cell, Diffuse trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Country / region: Singapore Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20092
20102
20112
20151
20163
20193
20211
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting4
Terminated4
Recruiting2
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Genmab2
Pfizer2
Regeneron Pharmaceuticals2
Singapore General Hospital2
Bayer1
Duke University1
GlaxoSmithKline1
Incyte Corporation1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse20
Lymphoma, B-Cell4
Lymphoma3
Lymphoma, Non-Hodgkin3
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Follicular2
Lymphoma, Mantle-Cell2
Recurrence2
Epstein-Barr Virus Infections1
Hematologic Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.